Although the debate regarding MR colonography screening lives on, European radiologists agree dark lumen MRC is ready for prime time, according to studies presented Tuesday.
Although the debate regarding MR colonography screening lives on, European radiologists agree dark lumen MRC is ready for prime time, according to studies presented Tuesday.
MRC has proved no better than CT colonography for detection of polyps smaller than 6 mm. But concerns about ionizing radiation exposure, especially in Europe, give MRC an advantage over CT when it comes to screening younger patient populations.
Dark lumen MR colonography may play an important role in colon cancer screening as a noninvasive alternative to CT in young, healthy patients. Increased contrast uptake of a polyp. (Provided by B. Bassler)
Dr. Boris Bassler and colleagues in the department of diagnostic and interventional radiology at the Klinikum Ludwigshafen, Germany, assessed 100 patients with dark lumen MRC who also had an indication for colonoscopy. They found MRC's sensitivity for adenomatous polyps ranging 6 mm to 9 mm, and larger than 9 mm, to be 84.2% and 100%, respectively.
The team could not detect hyperplastic polyps with MRC, and the sensitivity they observed for adenomatous lesions smaller than 6 mm was less than 20%. Such findings do not deter MRC imagers.
"There is still controversy with CT colonography screening regarding polyps under 6 mm. Many radiologists aren't sure if these are worth worrying about, so why should we?" Bassler said. "We are wondering how big CT colonography is getting in the U.S., since patients there don't seem particularly afraid of radiation. In Europe, political pressures from environmental groups have made people wary."
In another study, Swiss researchers assessed dark lumen MRC at 3T. Dr. Bettina Saar and colleagues at the University of Bern enrolled 23 patients previously referred for colonoscopy. Although they could not successfully translate all of the features of 1.5T into 3T, researchers found that the stronger magnetic field improves the detection of colorectal lesions. They also found that contrast-enhancement and the digital subtraction of images could help lesion characterization.
Another study by German researchers evaluated the accuracy of a new MRC protocol that favors fecal tagging over colonic cleansing. These investigators found fecal tagging MRC can be applied to screening, especially as patients are highly accepting of the procedure compared to standard colonoscopy and CT colonography.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.